Cargando…

Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada

Background: Continuous oral targeted therapies (OTT) represent a major economic burden on the Canadian healthcare system, due to their high cost and administration until disease progression/toxicity. The recent introduction of venetoclax-based fixed-duration combination therapies has the potential t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachaine, Jean, Guinan, Kimberly, Aw, Andrew, Banerji, Versha, Fleury, Isabelle, Owen, Carolyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217487/ https://www.ncbi.nlm.nih.gov/pubmed/37232797 http://dx.doi.org/10.3390/curroncol30050339

Ejemplares similares

Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
por: Lachaine, Jean, et al.
Publicado: (2021)

Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
por: Roy Chowdhury, Subir, et al.
Publicado: (2018)

Cost of illness and economic burden of chronic lymphocytic leukemia
por: Blankart, Carl Rudolf, et al.
Publicado: (2013)

Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost–Utility Analysis
por: Guinan, Kimberly, et al.
Publicado: (2022)

The economic burden of prematurity in Canada
por: Johnston, Karissa M, et al.
Publicado: (2014)

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia
por: Wu, Xun, et al.
Publicado: (2021)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
por: Kost, Sara E. F., et al.
Publicado: (2019)

Economic burden of chronic pain in Alberta, Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2022)

Economic burden of excessive sedentary behaviour in Canada
por: Chaput, Jean-Philippe, et al.
Publicado: (2023)

The economic burden of inadequate consumption of vegetables and fruit in Canada
por: Ekwaru, John Paul, et al.
Publicado: (2016)

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease
por: Kost, Sara E. F., et al.
Publicado: (2023)

A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada
por: Chatterjee, Anuja, et al.
Publicado: (2022)

Economic burden of illness associated with diabetic foot ulcers in Canada
por: Hopkins, Robert B, et al.
Publicado: (2015)

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2018)

Temporal changes in diet quality and the associated economic burden in Canada
por: Nshimyumukiza, Léon, et al.
Publicado: (2018)

The Economic Burden of Cancer in Canada from a Societal Perspective
por: Garaszczuk, Roxanne, et al.
Publicado: (2022)

Adherence to oral antiretroviral therapy in Canada, 2010–2020
por: Angel, Jonathan B., et al.
Publicado: (2023)

The Economic Burden of Acute Myeloid Leukemia in Iran
por: Alipour, Vahid, et al.
Publicado: (2022)

Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease
por: Benedetti, Edoardo, et al.
Publicado: (2023)

Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia
por: Bourrier, Nicole, et al.
Publicado: (2022)

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review
por: Ismaila, Afisi S, et al.
Publicado: (2013)

The economic burden of not meeting food recommendations in Canada: The cost of doing nothing
por: Lieffers, Jessica R. L., et al.
Publicado: (2018)

Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012)

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
por: Cerquozzi, Sonia, et al.
Publicado: (2015)

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
por: Chatterjee, Anuja, et al.
Publicado: (2021)

Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
por: Lachaine, Jean, et al.
Publicado: (2014)

Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective
por: Costello, Jacqueline, et al.
Publicado: (2021)

Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012–2013
por: Ouhoummane, Najwa, et al.
Publicado: (2019)

Economic burden and loss of quality of life from dry eye disease in Canada
por: Chan, Clara, et al.
Publicado: (2021)

Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia
por: Allan, John N., et al.
Publicado: (2023)

Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment
por: Roy Chowdhury, Subir, et al.
Publicado: (2020)

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

P641: REAL-WORLD DURATION OF VENETOCLAX TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA
por: Teschemaker, Anna, et al.
Publicado: (2023)

Burden of Respiratory Syncytial Virus Hospitalizations in Canada
por: Mitchell, Ian, et al.
Publicado: (2017)

The economic burden of excessive sugar consumption in Canada: should the scope of preventive action be broadened?
por: Liu, Siyuan, et al.
Publicado: (2022)

Incidence of acute lymphocytic leukemia in Calgary, Alberta, Canada: a retrospective cohort study
por: Snodgrass, Rayven, et al.
Publicado: (2018)

Fixed-Duration Therapy in Leprosy: Limitations and Opportunities
por: Malathi, Munisamy, et al.
Publicado: (2013)

Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs
por: Malits, Julia, et al.
Publicado: (2022)

The economic burden of oral cancer in Iran
por: Rezapour, Aziz, et al.
Publicado: (2018)

Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
por: Spooner, Kimberly L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i97jnpj1b7ai9ktm8q0j8tq6da